Bigul

SMS Lifesciences India Ltd - 540679 - Intimation Pursuant To Insider Trading

We received disclosure from Kantheti Gandhi - HUF (Relative of Independent Director) yesterday i.e. December 9, 2020, regarding acquisition of 3,000 equity shores of the Company between November 20, 2020 and November 25, 2020.
10-12-2020
Bigul

SMS Lifesciences India Ltd - 540679 - Disclosure Regarding Release Of Pledged Shares

Ref: Regulation 29(2) and 31(2) of SEBI (SAST) Regulations, 2011 read with SEBI circular no. CIR/CFD/POLICYCELL/3/2015 dated August 5, 2015
10-12-2020
Bigul

SMS Lifesciences India Ltd - 540679 - Intimation Pursuant To Insider Trading / SAST

DISCLOSURE FOR INTIMATION RECEIVED FROM PROMOTER / PROMOTER GROUP FOR ACQUISITION / DISPOSAL OF EQUITY SHARES OF THE COMPANY
09-12-2020
Bigul

SMS Lifesciences India Ltd - 540679 - Report Regarding Interse Transfer [Reg. 10(6)]

In furtherance to the intimation under Regulation 10(5) of SEBI (SAST) Regulations. 2011, submitted on November 27, 2020, acquirers have purchased 5,15,858 Equity Shares of the Company, by way of Inter-se transfer on December 8, 2020.
09-12-2020
Bigul

SMS Lifesciences India Ltd - 540679 - Consolidated Related Party Transactions [H1-F21]

Disclosure as per Reg. 23 (9) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
09-12-2020
Bigul

SMS Lifesciences India Ltd - 540679 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Potluri Laboratories Pvt Ltd
30-11-2020
Bigul

SMS Lifesciences India Ltd - 540679 - Intimation Received From Promoter / Promoter Group Regarding Inter-Se Transfer

In compliance with Regulation 10(5) of SEBI (SAST) Regulations, 2011, Company has received intimation from Promoter / Promoter Group for inter-se transfer of 5,15,958 Equity Shares of the Company, on or after December 7, 2020.
27-11-2020
Bigul

SMS Lifesciences India Ltd - 540679 - Disclosure Under Reg. 7(2) Of SEBI (PIT) Regulations, 2015 And Reg. 29(2) Of SEBI (SAST) Regulations, 2011

Company received intimation from Promoter / Promoter Group pursuant to Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 on November 25, 2020.
25-11-2020
Bigul

SMS Lifesciences India Ltd - 540679 - Outcome Of Board Meeting

We would like to inform you that the Board of Directors of the Company at their Meeting held today, has inter-alia considered and approved the unaudited [Standalone & Consolidated] Financial results for the quarter and half year ended September 30, 2020 along with limited review report.
13-11-2020
Next Page
Close

Let's Open Free Demat Account